Natco Pharma has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its Active Pharmaceutical Ingredient (API) facility in Mekaguda Village, Hyderabad which was conducted during the period August 5-9, 2019.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.